The results of network pharmacology and molecular docking showed that quercetin, isorhamnetin, and kaempferol exerted their therapeutic effects on chronic bronchitis by blocking the Fc epsilon RI signaling pathway, mitogen-activated protein kinase signaling pathway, and vascular endothelial growth factor signaling pathway. This evidence concerns the gene WNK2 and chronic bronchitis.